First-pass extracted concept

SMN-Gemins complex

Candidate: concept label1 source documents4 linked claims
Live refresh every 5sNext refresh in 5s

Aliases

SMN complex

Extracted Explainers

What the tool is doing

The SMN-Gemins complex is described as a molecular chaperone that assists assembly of the Sm protein core onto snRNAs to form snRNPs. In this review it is the central mechanistic complex linking low SMN to spliceosomal dysfunction.

Source 1DOIPubMed

Resources required

The abstract describes it as a multiprotein complex containing SMN together with Gemins 2-8 and Unrip, and acting in cooperation with the PRMT5 complex.

Source 1DOIPubMed

What problem it solves

It supports faithful snRNP assembly in cells, a prerequisite for normal spliceosome function.

Source 1DOIPubMed

What it does not solve

The abstract does not show that restoring this pathway alone is sufficient to fully explain or reverse selective neuromuscular degeneration.

Source 1DOIPubMed

Alternatives

The review contrasts SMN-centered defects with disruption of other snRNP assembly factors and with U1 snRNP perturbation as related routes to similar phenotypes.

Source 1DOIPubMed

Evidence Snippets

SMN is part of a multiprotein complex that also includes Gemins 2-8 and Unrip. The SMN-Gemins complex cooperates with the protein arginine methyltransferase 5 (PRMT5) complex.
Evidence 1Source 1DOIPubMedprovenance

Supporting Sources

Linked Claims

Claim 1disease mechanism summarysupports2017Source 1DOIPubMed

In vivo studies highlighted by the review point to disturbances in snRNP assembly and resulting transcriptome abnormalities as primary drivers of progressive neuromuscular degeneration in SMA.

Claim 2mechanistic summarysupports2017Source 1DOIPubMed

The SMN-Gemins complex and the PRMT5 complex function as molecular chaperones that assist assembly of the Sm protein core onto snRNAs to generate snRNPs.

Claim 3pathway consequence summarysupports2017Source 1DOIPubMed

Splicing defects described in SMA models can lead to DNA damage and stress responses that compromise survival of the motor system.

Claim 4therapeutic hypothesis summarysupports2017Source 1DOIPubMed

Restoring correct chaperoning of snRNP assembly is predicted to enhance the benefit of SMA therapeutic modalities based on augmenting SMN expression.